Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that once daily dosing of NCX 470 0.1%, a novel nitric oxide (NO)-donating bimatoprost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback